NO782571L - Antibakterielle sammensetninger. - Google Patents

Antibakterielle sammensetninger.

Info

Publication number
NO782571L
NO782571L NO782571A NO782571A NO782571L NO 782571 L NO782571 L NO 782571L NO 782571 A NO782571 A NO 782571A NO 782571 A NO782571 A NO 782571A NO 782571 L NO782571 L NO 782571L
Authority
NO
Norway
Prior art keywords
approx
acceptable salt
pharmaceutically acceptable
trimethoprim
phosphanilic acid
Prior art date
Application number
NO782571A
Other languages
English (en)
Norwegian (no)
Inventor
Georg Redl
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO782571L publication Critical patent/NO782571L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO782571A 1977-07-27 1978-07-26 Antibakterielle sammensetninger. NO782571L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/819,523 US4125610A (en) 1977-07-27 1977-07-27 Antibacterial compositions

Publications (1)

Publication Number Publication Date
NO782571L true NO782571L (no) 1979-01-30

Family

ID=25228386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782571A NO782571L (no) 1977-07-27 1978-07-26 Antibakterielle sammensetninger.

Country Status (20)

Country Link
US (1) US4125610A (fr)
JP (1) JPS5444037A (fr)
AU (1) AU520488B2 (fr)
BE (1) BE869319A (fr)
CA (1) CA1093969A (fr)
CH (1) CH636523A5 (fr)
DE (1) DE2833014A1 (fr)
DK (1) DK332278A (fr)
FI (1) FI782319A7 (fr)
FR (1) FR2398500A1 (fr)
GB (1) GB2001527B (fr)
GR (1) GR72424B (fr)
IE (1) IE47715B1 (fr)
IL (1) IL55210A (fr)
IT (1) IT1107232B (fr)
LU (1) LU80038A1 (fr)
NO (1) NO782571L (fr)
PH (1) PH14512A (fr)
SE (1) SE7808114L (fr)
ZA (1) ZA784193B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386952B (de) * 1979-04-26 1988-11-10 Bristol Myers Co Verfahren zur herstellung von antibakteriellen mischungen
CA1159834A (fr) * 1979-04-26 1984-01-03 Paul L. Warner, Jr. Sels de chlorhexidine et compositions qui en renferment
US4708952A (en) * 1985-02-06 1987-11-24 Aida Salatinjants Method of treatment of the infectious and viral diseases by one time interference
US5200402A (en) * 1991-10-24 1993-04-06 U.S. Army Medical Research & Development Command Anti microbial mafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor
GB0803948D0 (en) * 2008-03-03 2008-04-09 Habbal Magdi E Combination therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159573A (en) * 1961-03-30 1964-12-01 Smith Corp A O Resistance sensing probe system
BE793253A (fr) * 1971-12-23 1973-04-16 Lepetit Spa Nouvelles compositions bactericides et leur utilisation

Also Published As

Publication number Publication date
IL55210A (en) 1982-05-31
CA1093969A (fr) 1981-01-20
IE47715B1 (en) 1984-05-30
GR72424B (fr) 1983-11-04
AU3819178A (en) 1980-01-24
ZA784193B (en) 1979-07-25
IL55210A0 (en) 1978-09-29
IE781509L (en) 1979-01-27
SE7808114L (sv) 1979-01-28
FI782319A7 (fi) 1979-01-28
CH636523A5 (de) 1983-06-15
DE2833014A1 (de) 1979-02-15
IT7850441A0 (it) 1978-07-24
GB2001527A (en) 1979-02-07
BE869319A (fr) 1979-01-29
DK332278A (da) 1979-01-28
AU520488B2 (en) 1982-02-04
PH14512A (en) 1981-08-24
FR2398500B1 (fr) 1980-10-31
FR2398500A1 (fr) 1979-02-23
US4125610A (en) 1978-11-14
IT1107232B (it) 1985-11-25
JPS5444037A (en) 1979-04-07
LU80038A1 (fr) 1979-04-09
GB2001527B (en) 1982-01-20

Similar Documents

Publication Publication Date Title
SA519401123B1 (ar) مركبات دوائية مفيدة في المعالجة الوقائية أو الدوائية للعدوى بفيروس نقص المناعة
JP5709354B2 (ja) mTOR阻害剤投与によるがん患者の治療
NO156373B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
US20140243273A1 (en) Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
WO2019029319A1 (fr) Produit composite contenant un composé de limonine et un composé de biguanide
US20230225977A1 (en) Formulation comprising daprodustat
US6242424B1 (en) Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
CN115745907B (zh) 一种抗菌抗肿瘤增效剂及其合成方法与应用
US4125610A (en) Antibacterial compositions
CN110302201B (zh) 苯乙烯喹啉衍生物在制备抗耐药菌药物中的应用和抗耐药菌药物
CN102295609B (zh) 2-[(取代苯氨基)羰基甲硫基]-6-环己甲基-3h-嘧啶-4-酮类化合物、其合成方法及用途
JP2003510362A (ja) 細胞内原核生物、dnaウイルス及びレトロウイルスによる感染を治療するための、3−ヒドロキシ−4−ピロンのガリウム錯体
US3852450A (en) Antibacterial compositions containing rifampicin and a pyrimidine derivative
US4233315A (en) Analgesic potentiation
MXPA06003479A (es) Una composicion farmaceutica de liberacion prolongada y un proceso para su preparacion.
US3515783A (en) Antibacterial composition containing 5-methyl - 3 - sulfanilamidoisoxazole and trimethoxybenzyl pyrimidine
CN115192593B (zh) 柔红霉素在治疗多重耐药菌感染疾病中的应用
JPS6036409B2 (ja) 微生物感染処置用組成物
CN101756924A (zh) 法罗培南钠的缓释片
US5118799A (en) Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
De Koning et al. Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
CA2250844C (fr) Composition anti-vih contenant un derive d'imidazole
EP0291488A2 (fr) Dérivé d'érythromycine et sa préparation et utilisation
Jackson The key role of aminoglycosides in antibacterial therapy and prophylaxis
CN119326747A (zh) 一种松萝酸在制备抗副溶血性弧菌药物中的应用、药物组合物及其应用